These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 3145820
1. Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment. Page MD, Dieguez C, Valcavi R, Edwards C, Hall R, Scanlon MF. Clin Endocrinol (Oxf); 1988 May; 28(5):551-8. PubMed ID: 3145820 [Abstract] [Full Text] [Related]
2. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine. Procopio M, Maccario M, Grottoli S, Oleandri SE, Boffano GM, Camanni F, Ghigo E. Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266 [Abstract] [Full Text] [Related]
4. Interaction of L-dopa and GHRH on GH secretion in normal men. Alba-Roth J, von Creytz C, Mehltretter G, Schopohl J, Müller OA, von Werder K. J Endocrinol Invest; 1989 Dec; 12(11):783-7. PubMed ID: 2515218 [Abstract] [Full Text] [Related]
5. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. Arvat E, Gianotti L, Grottoli S, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F, Ghigo E. J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341 [Abstract] [Full Text] [Related]
6. Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine. Ghigo E, Bellone J, Mazza E, Imperiale E, Procopio M, Valente F, Lala R, De Sanctis C, Camanni F. Clin Endocrinol (Oxf); 1990 Jun; 32(6):763-7. PubMed ID: 1974484 [Abstract] [Full Text] [Related]
7. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man. Arvat E, Di Vito L, Ramunni J, Gianotti L, Giordano R, Deghenghi R, Camanni F, Ghigo E. Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449 [Abstract] [Full Text] [Related]
8. [Effect of oral administration of L-dopa on the plasma levels of growth hormone-releasing hormone (GHRH) in normal subjects and patients with various endocrine and metabolic diseases]. Mitsuhashi S, Yamasaki R, Miyazaki S, Saito H, Saito S. Nihon Naibunpi Gakkai Zasshi; 1987 Aug 20; 63(8):934-46. PubMed ID: 3123283 [Abstract] [Full Text] [Related]
9. Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects. Ghigo E, Ceda GP, Valcavi R, Goffi S, Zini M, Mucci M, Valenti G, Cocchi D, Müller EE, Camanni F. J Endocrinol Invest; 1994 Feb 20; 17(2):113-7. PubMed ID: 8006330 [Abstract] [Full Text] [Related]
10. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback. Ismail IS, Scanlon MF, Peters JR. Clin Endocrinol (Oxf); 1993 Feb 20; 38(2):149-57. PubMed ID: 8094648 [Abstract] [Full Text] [Related]
11. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. Alba-Roth J, Müller OA, Schopohl J, von Werder K. J Clin Endocrinol Metab; 1988 Dec 20; 67(6):1186-9. PubMed ID: 2903866 [Abstract] [Full Text] [Related]
12. Methionine potentiates both basal and GHRH-induced GH secretion in children. Bellone J, Farello G, Bartolotta E, Aimaretti G, Bellone S, Mucci M, De Matteis F, Ghigo E. Clin Endocrinol (Oxf); 1997 Jul 20; 47(1):61-4. PubMed ID: 9302373 [Abstract] [Full Text] [Related]
13. Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity. Maccario M, Procopio M, Grottoli S, Oleandri SE, Boffano GM, Taliano M, Camanni F, Ghigo E. Metabolism; 1996 Mar 20; 45(3):342-6. PubMed ID: 8606641 [Abstract] [Full Text] [Related]
14. Interaction of the growth hormone releasing peptide hexarelin with somatostatin. Massoud AF, Hindmarsh PC, Brook CG. Clin Endocrinol (Oxf); 1997 Nov 20; 47(5):537-47. PubMed ID: 9425393 [Abstract] [Full Text] [Related]
15. Differential effects of arginine on growth hormone releasing hormone and insulin induced growth hormone secretion. Koppeschaar HP, ten Horn CD, Thijssen JH, Page MD, Dieguez C, Scanlon MF. Clin Endocrinol (Oxf); 1992 May 20; 36(5):487-90. PubMed ID: 1617799 [Abstract] [Full Text] [Related]
16. Activation of cholinergic tone by pyridostigmine reverses the inhibitory effect of corticotropin-releasing hormone on the growth hormone-releasing hormone-induced growth hormone secretion. Corsello SM, Tofani A, Della Casa S, Sciuto R, Rota CA, Colasanti S, Bini A, Barini A, Barbarino A. Acta Endocrinol (Copenh); 1992 Feb 20; 126(2):113-6. PubMed ID: 1543015 [Abstract] [Full Text] [Related]
17. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects. Hanew K, Tanaka A, Utsumi A, Sugawara A, Abe K. J Clin Endocrinol Metab; 1996 May 20; 81(5):1952-5. PubMed ID: 8626863 [Abstract] [Full Text] [Related]
18. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. Ghigo E, Goffi S, Nicolosi M, Arvat E, Valente F, Mazza E, Ghigo MC, Camanni F. J Clin Endocrinol Metab; 1990 Dec 20; 71(6):1481-5. PubMed ID: 2229304 [Abstract] [Full Text] [Related]
19. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome. Procopio M, Invitti C, Maccario M, Grottoli S, Cavagnini F, Camanni F, Ghigo E. Int J Obes Relat Metab Disord; 1995 Feb 20; 19(2):108-12. PubMed ID: 7735336 [Abstract] [Full Text] [Related]
20. Effect of digoxin on the somatotroph responsiveness to growth hormone-releasing hormone (GHRH) alone or combined with arginine in normal young volunteers. Broglio F, Benso A, Gottero C, Vito LD, Granata R, Arvat E, Bobbio M, Trevi G, Ghigo E. Clin Endocrinol (Oxf); 2001 Dec 20; 55(6):755-8. PubMed ID: 11895217 [Abstract] [Full Text] [Related] Page: [Next] [New Search]